Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

[PI3K-AKT network roles in infectious diseases].

Noguchi M, Kinowaki K.

Kansenshogaku Zasshi. 2008 May;82(3):161-7. Review. Japanese.

PMID:
18546844
2.

Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.

McCubrey JA, Steelman LS, Abrams SL, Lee JT, Chang F, Bertrand FE, Navolanic PM, Terrian DM, Franklin RA, D'Assoro AB, Salisbury JL, Mazzarino MC, Stivala F, Libra M.

Adv Enzyme Regul. 2006;46:249-79. Epub 2006 Jul 18.

PMID:
16854453
3.

A minireview: the role of MAPK/ERK and PI3K/Akt pathways in thyroid follicular cell-derived neoplasm.

Brzezianska E, Pastuszak-Lewandoska D.

Front Biosci (Landmark Ed). 2011 Jan 1;16:422-39. Review.

PMID:
21196179
4.

Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy.

Chang F, Lee JT, Navolanic PM, Steelman LS, Shelton JG, Blalock WL, Franklin RA, McCubrey JA.

Leukemia. 2003 Mar;17(3):590-603. Review.

PMID:
12646949
5.

Interactions between the PI3K and Raf signaling pathways can result in the transformation of hematopoietic cells.

McCubrey JA, Lee JT, Steelman LS, Blalock WL, Moye PW, Chang F, Pearce M, Shelton JG, White MK, Franklin RA, Pohnert SC.

Cancer Detect Prev. 2001;25(4):375-93.

PMID:
11531015
6.

Opposite effects of Ha-Ras and Ki-Ras on radiation-induced apoptosis via differential activation of PI3K/Akt and Rac/p38 mitogen-activated protein kinase signaling pathways.

Choi JA, Park MT, Kang CM, Um HD, Bae S, Lee KH, Kim TH, Kim JH, Cho CK, Lee YS, Chung HY, Lee SJ.

Oncogene. 2004 Jan 8;23(1):9-20.

PMID:
14712206
7.

Effects of AFP-activated PI3K/Akt signaling pathway on cell proliferation of liver cancer.

Zheng L, Gong W, Liang P, Huang X, You N, Han KQ, Li YM, Li J.

Tumour Biol. 2014 May;35(5):4095-9. doi: 10.1007/s13277-013-1535-z. Epub 2014 Jan 15.

PMID:
24425104
8.

[Genetic alterations in MAPK and PI3K/Akt signaling pathways and the generation, progression, diagnosis and therapy of thyroid cancer].

Liu B, Kuang A.

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2012 Dec;29(6):1221-5. Review. Chinese.

PMID:
23469561
9.

Epstein-Barr virus upregulates phosphorylated heat shock protein 27 kDa in carcinoma cells using the phosphoinositide 3-kinase/Akt pathway.

Fukagawa Y, Nishikawa J, Kuramitsu Y, Iwakiri D, Takada K, Imai S, Satake M, Okamoto T, Fujimoto M, Okita K, Nakamura K, Sakaida I.

Electrophoresis. 2008 Aug;29(15):3192-200. doi: 10.1002/elps.200800086.

PMID:
18604870
10.
11.

Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway.

Meng Q, Xia C, Fang J, Rojanasakul Y, Jiang BH.

Cell Signal. 2006 Dec;18(12):2262-71. Epub 2006 Jun 2.

PMID:
16839745
12.

HijAkt: The PI3K/Akt pathway in virus replication and pathogenesis.

Dunn EF, Connor JH.

Prog Mol Biol Transl Sci. 2012;106:223-50. doi: 10.1016/B978-0-12-396456-4.00002-X. Review.

PMID:
22340720
13.

Phosphoinositide-3 kinase-PKB/Akt pathway activation is involved in fibroblast Rat-1 transformation by human T-cell leukemia virus type I tax.

Liu Y, Wang Y, Yamakuchi M, Masuda S, Tokioka T, Yamaoka S, Maruyama I, Kitajima I.

Oncogene. 2001 May 3;20(20):2514-26.

14.

Role of phosphatidylinositol 3-kinase-Akt pathway in nucleophosmin/anaplastic lymphoma kinase-mediated lymphomagenesis.

Slupianek A, Nieborowska-Skorska M, Hoser G, Morrione A, Majewski M, Xue L, Morris SW, Wasik MA, Skorski T.

Cancer Res. 2001 Mar 1;61(5):2194-9.

15.

Opposing extracellular signal-regulated kinase and Akt pathways control Schwann cell myelination.

Ogata T, Iijima S, Hoshikawa S, Miura T, Yamamoto S, Oda H, Nakamura K, Tanaka S.

J Neurosci. 2004 Jul 28;24(30):6724-32.

16.

A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.

Korkolopoulou P, Levidou G, Trigka EA, Prekete N, Karlou M, Thymara I, Sakellariou S, Fragkou P, Isaiadis D, Pavlopoulos P, Patsouris E, Saetta AA.

BJU Int. 2012 Dec;110(11 Pt C):E1237-48. doi: 10.1111/j.1464-410X.2012.11569.x. Epub 2012 Oct 29.

17.

G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells.

Gao N, Flynn DC, Zhang Z, Zhong XS, Walker V, Liu KJ, Shi X, Jiang BH.

Am J Physiol Cell Physiol. 2004 Aug;287(2):C281-91. Epub 2004 Mar 17.

18.

The Akt-SREBP nexus: cell signaling meets lipid metabolism.

Krycer JR, Sharpe LJ, Luu W, Brown AJ.

Trends Endocrinol Metab. 2010 May;21(5):268-76. doi: 10.1016/j.tem.2010.01.001. Epub 2010 Feb 1. Review.

PMID:
20117946
19.

Portrait of the PI3K/AKT pathway in colorectal cancer.

Danielsen SA, Eide PW, Nesbakken A, Guren T, Leithe E, Lothe RA.

Biochim Biophys Acta. 2015 Jan;1855(1):104-21. doi: 10.1016/j.bbcan.2014.09.008. Epub 2014 Nov 22. Review.

PMID:
25450577
20.

Effects of the RAF/MEK/ERK and PI3K/AKT signal transduction pathways on the abrogation of cytokine-dependence and prevention of apoptosis in hematopoietic cells.

Shelton JG, Steelman LS, Lee JT, Knapp SL, Blalock WL, Moye PW, Franklin RA, Pohnert SC, Mirza AM, McMahon M, McCubrey JA.

Oncogene. 2003 Apr 24;22(16):2478-92.

PMID:
12717425
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk